Responses
Regular and young investigator award abstracts
Clinical trials in progress
321 Phase I clinical trial assessing the combination of systemic chemokine modulatory regimen targeting TLR3 with neoadjuvant chemotherapy in triple negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
